Physiologic considerations in the management of hemophilia.
D000614:Aminocaproates / Q000627:therapeutic use; D001777:Blood Coagulation; D001803:Blood Transfusion; D005164:Factor IX / Q000037:antagonists & inhibitors; D005165:Factor V / Q000502:physiology; D005169:Factor VIII / Q000096:biosynthesis / Q000302:isolation & purification / Q000378:metabolism; D005174:Factor XII / Q000502:physiology; D005612:Freeze Drying; D006467:Hemophilia A / Q000188:drug therapy / Q000235:genetics / Q000276:immunology / Q000628:therapy*; D002836:Hemophilia B / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans
D000614:Aminocaproates; D005165:Factor V; D005169:Factor VIII; D005164:Factor IX; D005174:Factor XII